HIPK2 and Sepsis: Based on this premise, the 16-day survival rate was 16.7% (5 of 30 mice) in the CLP-induced sepsis group, 60.0% (18 of 30 mice) in the Ad-HIPK2-injected sepsis group, 6.67% (2 of 30 mice) in the Ad-shHIPK2-injected sepsis group (Fig. 2c) and 100% in the control group (30 mice).